GATM and cancer: We also found that glycine amidinotransferase (GATM), the rate-limiting enzyme for creatine synthesis, is up-regulated in GBM, which is reported to mediate de novo synthesis of creatine, and enhance cancer metastasis and shortens mouse survival [22].